1788872-06-9
Chemical Structure
Nav1.7-IN-3
- CAS No.: 1788872-06-9
- Formula:C17H20ClFN4O2S2
- Molecular Weight:430.95
IUPAC Name: 5-chloro-2-fluoro-4-(((tetrahydro-1H-pyrrolizin-7a(5H)-yl)methyl)amino)-N-(thiazol-2-yl)benzenesulfonamide
InChIKey: XFWKBJBSEOZBRA-UHFFFAOYSA-N
SMILES: FC1=C(S(=O)(NC2=NC=CS2)=O)C=C(Cl)C(NCC34CCCN3CCC4)=C1
Biological Activity: Nav1.7-IN-3 is a selective, orally bioavailable voltage-gated sodium channel Nav1.7 inhibitor with an IC50 of 8 nM. Pain relief. Limited CNS penetration[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Nav1.7-IN-3 | 98.21% | Nav1.7-IN-3 is a selective, orally bioavailable voltage-gated sodium channel Nav1.7 inhibitor with an IC50 of 8 nM. Pain relief. Limited CNS penetration. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Nav1.7-IN-3 (Standard) | ≥98% | Nav1.7-IN-3 (Standard) is the analytical standard of Nav1.7-IN-3 (HY-101789). This product is intended for research and analytical applications. Nav1.7-IN-3 is a selective, orally bioavailable voltage-gated sodium channel Nav1.7 inhibitor with an IC50 of 8 nM. Pain relief. Limited CNS penetration. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords